ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/01/2025
Back to search
Official data from USPTO
THERAPY ACCELERATION PROGRAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
THERAPY ACCELERATION PROGRAM
ST13
US500000076712460Class
42
Filing
76712460
Registration
4336604
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/02/2025
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
09/21/2012
Registration date
05/21/2013
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/09/2023
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/07/2006
First use in commerce
06/07/2006
Drawing code
4
Owner type
99
Owner location
WASHINGTON, DC
Examiner
POVARCHUK,REBECCA JOYCE
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
BLOOD CANCER UNITED , INC.
Leukemia & Lymphoma Society, Inc., The
Representatives
Andrew D. Price Venable LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
MEDICAL RESEARCH SERVICES IN THE FIELD OF BLOOD RELATED CANCERS
Publications
History of USPTO decisions and trademark events.
31 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/09/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/09/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/09/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/16/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/21/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/20/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/20/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/20/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/13/2019
E815
TEAS SECTION 8 & 15 RECEIVED
05/13/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/10/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/10/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/21/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/06/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/06/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/18/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/18/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2013
PUBO
PUBLISHED FOR OPPOSITION
03/05/2013
NPUB
NOTICE OF PUBLICATION
02/13/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/30/2013
ALIE
ASSIGNED TO LIE
01/30/2013
CNEA
EXAMINER'S AMENDMENT MAILED
01/24/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2013
DOCK
ASSIGNED TO EXAMINER
01/21/2013
MAFR
APPLICATION FILING RECEIPT MAILED
09/29/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/25/2012
Continuous trademark protection
Get notified about every new filing that threatens THERAPY ACCELERATION PROGRAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.